Literature DB >> 9346236

The homeobox gene GBX2, a target of the myb oncogene, mediates autocrine growth and monocyte differentiation.

E Kowenz-Leutz1, P Herr, K Niss, A Leutz.   

Abstract

The homeobox gene GBX2 was identified as a target gene of the v-Myb oncoprotein encoded by the avian myeloblastosis virus (AMV). GBX2 activation by c-Myb requires signal transduction emanating from the cell surface while the leukemogenic AMV v-Myb constitutively induces the GBX2 gene. Mutations in the DNA binding domain of AMV-Myb render it independent of signaling events and concomitantly abrogate the collaboration between Myb and CCAAT Enhancer Binding Proteins (C/EBP), which are involved in granulocyte differentiation. Ectopic expression of GBX2 in growth factor-dependent myeloblasts induces monocytic features and independence from exogenous cytokines, reflecting distinct features of AMV-transformed cells. Our results suggest that Myb or factors it interacts with contribute to hematopoietic lineage choice and differentiation in a signal transduction-dependent fashion.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9346236     DOI: 10.1016/s0092-8674(00)80401-8

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  21 in total

1.  MafB is an inducer of monocytic differentiation.

Authors:  L M Kelly; U Englmeier; I Lafon; M H Sieweke; T Graf
Journal:  EMBO J       Date:  2000-05-02       Impact factor: 11.598

2.  Signaling through regulated transcription factor interaction: mapping of a regulatory interaction domain in the Myb-related Bas1p.

Authors:  B Pinson; T L Kongsrud; E Ording; L Johansen; B Daignan-Fornier; O S Gabrielsen
Journal:  Nucleic Acids Res       Date:  2000-12-01       Impact factor: 16.971

3.  v-Myb mediates cooperation of a cell-specific enhancer with the mim-1 promoter.

Authors:  Olesya Chayka; Jörg Kintscher; Daniel Braas; Karl-Heinz Klempnauer
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

4.  TRAF7 sequesters c-Myb to the cytoplasm by stimulating its sumoylation.

Authors:  Yutaka Morita; Chie Kanei-Ishii; Teruaki Nomura; Shunsuke Ishii
Journal:  Mol Biol Cell       Date:  2005-09-14       Impact factor: 4.138

5.  Gbx2 and Otx2 interact with the WD40 domain of Groucho/Tle corepressors.

Authors:  Thomas Heimbucher; Christina Murko; Baubak Bajoghli; Narges Aghaallaei; Anja Huber; Ronald Stebegg; Dirk Eberhard; Maria Fink; Antonio Simeone; Thomas Czerny
Journal:  Mol Cell Biol       Date:  2006-10-23       Impact factor: 4.272

6.  Fbxw7 acts as an E3 ubiquitin ligase that targets c-Myb for nemo-like kinase (NLK)-induced degradation.

Authors:  Chie Kanei-Ishii; Teruaki Nomura; Tsuyoshi Takagi; Nobumoto Watanabe; Keiichi I Nakayama; Shunsuke Ishii
Journal:  J Biol Chem       Date:  2008-09-02       Impact factor: 5.157

7.  Revealing system-level correlations between aging and calorie restriction using a mouse transcriptome.

Authors:  Seong-Eui Hong; Hyoung-Sam Heo; Dae Hyun Kim; Min-Sun Kim; Chul Hong Kim; Jaewon Lee; Mi-Ae Yoo; Byung Pal Yu; Christiaan Leeuwenburgh; Hae Young Chung
Journal:  Age (Dordr)       Date:  2009-07-10

8.  IkappaB kinase-dependent chronic activation of NF-kappaB is necessary for p21(WAF1/Cip1) inhibition of differentiation-induced apoptosis of monocytes.

Authors:  K N Pennington; J A Taylor; G D Bren; C V Paya
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

9.  Wnt-1 signal induces phosphorylation and degradation of c-Myb protein via TAK1, HIPK2, and NLK.

Authors:  Chie Kanei-Ishii; Jun Ninomiya-Tsuji; Jun Tanikawa; Teruaki Nomura; Tohru Ishitani; Satoshi Kishida; Kenji Kokura; Toshihiro Kurahashi; Emi Ichikawa-Iwata; Yongsok Kim; Kunihiro Matsumoto; Shunsuke Ishii
Journal:  Genes Dev       Date:  2004-04-01       Impact factor: 11.361

10.  The glioma-amplified sequence 41 gene (GAS41) is a direct Myb target gene.

Authors:  Daniel Braas; Holger Gundelach; Karl-Heinz Klempnauer
Journal:  Nucleic Acids Res       Date:  2004-09-08       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.